Become a Member

“Alzheimer’s ‘Miracle Cure’ Discovered — Your Key to an Untapped $189 Billion Market”

This is all hush-hush, you understand — I’m taking terrible risks by just writing to you today.

And my intrepid readers, members of the resistance, have also pushed the limits in sharing this news. The ad makes this very clear — it came with the subject line, “WARNING! Do Not Share, Do Not Forward”

But they did, my friends — that’s just how hard the mighty Gumshoe readers fight to make sure that profitable (maybe) information can reach our greedy little fists. One of them included this terse message:

“I have forwarded this message in defiance of instructions; please do not report me to Louis Navellier.”

Have no worries, my friends — your secret is safe with the Gumshoe.

And yes, that’s who is pitching this ad our way: Louis Navellier. He’s doing so — and, of course, using the silly language to make us feel like secret agents — in order to get new subscribers to one of his less expensive newsletters, Blue Chip Growth (“on sale” for $100/year at the moment).

But still, when you tell me you’ve got an Alzheimer’s stock that might actually produce something to help those suffering from this disease … well, that catches my attention. Not just because I’m such a well-known humanitarian, but because curing Alzheimer’s would make the dollar bill signs spin through your eyeballs so fast that you’d likely faint. This is one of the huge unmet areas of pharmaceutical demand — which is why the search for an Alzheimer’s cure always finds investors, and, of course, why so many little biotech stocks have crashed and burned in the effort to develop new compounds for this disease.

So what’s our stock?

Here’s how Louis introduces it:

“Breaking News

“Alzheimer’s ‘Miracle Cure’ Discovered

“What You Need to Know about the BIGGEST Medical Secret of our Lifetime….

“Stage Set for Massive Run-UP

“—Patented drug on verge of ‘Double Blockbuster’ status… could claim top spot in TWO of world’s fastest-growing medical markets

“—New £100,000 grant awarded to verify results.”

That’s actually almost enough to feed into the Thinkolator, right there in the headline. But then Navellier gets into the details a bit more just to give us a chance to be double-dog sure of our results:

“I’ve been telling my growth-stock readers to buy a Danish pharma superstar since June 2010…

“Even today, with its diabetes ‘miracle drug’ posting a 191% sales surge in the latest quarter alone…

“And with company officials predicting blockbuster sales of $1 billion by December…

“It’s small beans compared to what may lie just ahead for us.

“You see, while almost no one was looking, a German-born scientist discovered ‘promising indications’ that this very same diabetes drug also triggers brain cell growth and protects memory formation!

“In fact, Alzheimer’s Research U.K. is so impressed that they awarded his team a £99,221 grant to further their research.”

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


OK, so I could bore you with more of Louis’ blather — but, frankly, I’m likely to spit out so much of that myself that it seems unfair. So I’ll just take that abundant pile of clues, puree them nicely, pour ’em right into the Thinkolator, five minutes of processing and out the other side comes a delightful Jell-o mold of …

Novo Nordisk (NVO for the US ADR, the home trading is done in Copenhagen at NOVO, but the ADR is huge and liquid for this mega-cap company)

Yes, this is a “blue chip” company, per the focus of Navellier’s newsletter — it’s a $70 billion market cap global healthcare colossus that happens to be headquartered in Denmark.

And it’s not just that Novo Nordisk has a diabetes “Miracle Cure” (that’s arguable — there are a lot of competing products), but they are really a diabetes company, the vast majority of their sales come from various diabetes treatments and from insulin and insulin delivery systems. They do have other drugs in their pharma pipeline, including treatments for obesity and hemophilia that are fairly advanced, and several hormanal treatments (hormone replacement and growth hormontes), but most of them are either focused on diabetes or its side effects, or are diabetes drugs that they’re testing to see how they work on other diseases.

Which is the case with what Navellier is teasing here — he’s talking about their latest diabetes drug to get FDA approval (last year, I think), liraglutide — brand name Victoza.

And Victoza seems to be doing quite well — this is an injectable diabetes drug, and part of the appeal for diabetes treatments is decreasing the number of injections required. The previous standard drug, Byetta, requires two injections a day, apparently, and Victoza works with just one … and there are also competing drugs looking for approval that are oral, which is obviously more appealing if the drug works for you, or injectable less often (there’s a weekly version of Byetta called Bydureon from Eli Lilly and Amylin that is possibly going to get approved next year — they had a surprising delay from the FDA last Fall). Some of the next generation oral diabetes drugs have had troubles, too, so the competitive landscape seems to be very fluid but there seems to be quite a bit of demand for Victoza, at least so far.

And yes, it is being studied for Alzheimer’s — though to say that it’s a billion-dollar opportunity just now is probably a bit ambitious, it’s not that they’re entering phase III trials or anything — they’re just starting to study the drug for Alzheimer’s, thanks to that grant in the UK, and the general rule about Alzheimer’s drugs is that they have a very, very slow approval process. This is, after all, the brain we’re talking about, and a disease that we still don’t really understand very well.

There may be cause for optimism because it’s a drug that’s already considered pretty safe and in heavy usage, so by the time we learn anything about the impact on Alzheimer’s, if any, perhaps Victoza will have had so much use that it will be easy to add indications to the label without safety fears, I have no idea. Regardless, I wouldn’t expect Alzheimer’s news next week.

Novo Nordisk is, as I said, a big company — it takes big things to move the stock price in any abrupt fashion. The far bigger trend, I’d argue, is the continuing rapid increase in diabetes in the western world, and the likelihood that as emerging market middle classes follow our dietary path they’ll find the same fate — NVO’s core market is growing and shows no sign of stopping growth, and they’re close to being a “pure play” on diabetes … which is why they’re not cheap like many of the other big pharmaceutical companies are, they trade at a trailing PE of about 25 and a forward estimated PE of 19, with analysts expecting 15% annual growth in earnings for the next five years (how would they know? They don’t, it’s somewhere between a forecast and a guess).

The yield is also paltry compared to competitors like Pfizer (PFE), Eli Lilly (LLY) or Novartis (NVS), which have dividend yields ranging from 3-5% — but those stocks have also been flat or down somewhat over the last five years, while NVO has risen some 300%, so there’s a reason that it’s more expensive. One reason is that their strong recurring businesses in insulin and diabetes management don’t necessarily face the same kind of generic competition and “patent cliff” concerns as many blockbuster-dependent pharmas, though NVO does still have those same concerns to an (arguably) lesser degree.

So … are you ready to buy into this “double blockbuster?” Louis Navellier loves growth companies, so it’s not surprising to see him embrace a stock that is priced for growth — is it a good prescription for your portfolio? Let us know with a comment below.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

38 Comments
Inline Feedbacks
View all comments
MEKeyes
Guest
MEKeyes
July 21, 2011 10:45 am

Kind of pricey. How about Gilead?

ddugger
Guest
ddugger
July 21, 2011 10:46 am

Cancer, diabetes, Alzheimer's, and a host of other diseases are the bread and butter of the parasitical pharmaceutical, health care and insurance industries, so don't expect any flat out cures that will compete with their gravy train of marginal symptom resolvers. In fact, can you think of any actual major cures since polio's Salk vaccine? There is no money in cures, but much more to be milked from relieving symptoms. So, I personally wouldn't put a dime in this rumored cure of Alzheimer's.

Add a Topic
3397
Add a Topic
4154
Add a Topic
882
Joan in Houston
Joan in Houston
July 21, 2011 11:05 am

Pursuant to the "Miracle Cure" advertisement, here is an idea more down-to-earth:
I often listen to Doctor Isadore Rosenfeld (spelling?) on the Fox News Channel on Sunday mornings. He speaks in layman's language, and is often quite informative. He recently commented that a new research study had shown that folks who drank two to three cups of coffee a day reduced their risk of losing cognitive skills in old age. I therefore decided that I had better teach myself to like coffee.

Add a Topic
3838
Add a Topic
3838
John
Guest
John
July 21, 2011 12:00 pm

Having used Victoza and actually read the four flyers they send with it, Victoza is not without its detriments. As Doctor Isadore Rosenfeld has said there is a little poison in every drug, Victoza can cause a bunch of bad side effects including pancreatitis, thyroid cancer, and "Constipation; decreased appetite; diarrhea; dizziness; headache; nausea; pain, swelling, or redness at the injection site; sinus inflammation; sore throat; upset stomach; vomiting."

When I started getting pain in the vicinity of my pancreas, I dropped it like a hot potato. Sometimes the old reliable (cheaper) drugs are as good or better for the patient but not as big a revenue stream for big pharma.

Add a Topic
3397
Add a Topic
5554
Pam
Guest
Pam
July 21, 2011 12:19 pm

Within the last few months, I saw and read several articles/interviews about new research findings that show that Alzheimer's is equivalent to "diabetes in the brain". These were not related to a drug or a company. Just medical research. So…who knows? Wouldn't it be wonderful?

Add a Topic
4154
Raymond
Guest
Raymond
July 21, 2011 1:09 pm

In the summer of 2008, I lost $150,000 listening to my "Louis Navellier newsletter".

Add a Topic
2285
Advantedges
Guest
Advantedges
July 21, 2011 1:26 pm

While I am not a doctor, I just spent 8 years watching the effect of Alzheimer's on my Mother, and other patients at the rehab center and assisted living facility. I would suggest gumshoe readers get educated before commenting on the disease (and NVO)… what we do know about Alzheimer's is that it is a result of heredity, diet, lifestyle, aging and possibly environment. We all need to realize that the disease manifests itself through "plaque" on the brain. A neurologist showed me the brain scan that proved that my Mom had plaque on the brain….of course I also considered that I would have the same condition as I aged. The doctor agreed, suggesting heredity and similar lifestyle are major factors in the condition, much like the association between plaque and heart disease.
If NVO can demonstrate that they have developed a drug to remove the plaque build up on the brain, (without significant side effects) then it is likely that the sales of such a drug would be robust — if it is approved, prescribed and authorized. Let's all hope the drug works and is approved – and patients benefit from it's use. Meanwhile, if our diet or other factors are increasing the likelihood that we will have an increase in the occurrence of Alzheimer's
disease, then we all need to know so we can make necessary changes, (which wise people are already doing. Unfortunately, the weight gain crisis in the US suggests most people are not very wise!).

Add a Topic
5198
Add a Topic
5023
Add a Topic
5198
bill
bill
July 21, 2011 1:59 pm

i read about small doses of insuline sprayed into the nose being helpful in stopping alzhiemers or so the study said

Brian Cheary
July 21, 2011 2:55 pm

As a subscriber to Blue Chip Growth, my problem with Louis is that by the time he starts pushing a stock it is usually too expensive for the average small timer like myself. A few years ago my wife owned about 100 share of Apple at a time when their shares were around $90. Apple was having a few problems at that tome and Louis downgraded the stock to a sell. My wife still fumes to this day. We made some money at the time. A year or so after we sold the stock started climbing again and Louis got back on the band wagon and started promoting it but by that time we couldn't afford to buy back into it!

Add a Topic
5971
Add a Topic
5971
Add a Topic
5971
Advantedges
Guest
July 21, 2011 4:15 pm

Louis has had a buy recommendation on Apple for a long time…..if you subscribed since the 2008-2009 correction, you are happy w/ apple as a buy/hold. Hasn’t been @90 for a while. Hope your wife is into ETF ‘s now. QQQ holds Apple. So does XLK.

Add a Topic
900
Harold Anderson
Member
July 21, 2011 4:45 pm

Today's the last day of ICAD, the International Conference on Alzheimer's Disease, in France.

It's my understanding that many of the promising AD therapies have had set backs. Apparently getting a drug developed to improve AD patients isn't all that easy.

I invested in Elan Pharmaceuticals in 2001 because they'd shown that their AD drug cleared the plaque from mice brains and the mice responded by acting normally again. However, they're having a hard time getting the drug to work on humans. A big part of the presentations at ICAD related to brain inflammation, apparently a side effect of all AD treatments in the pipeline.

Elan's drug, bapineuzumab, has led to other drug therapies such as Tysabri for MS and other disorders. Bapi now has shared ownership with Elan, JNJ, and Pfizer.

Even with bapi, we don't expect to know if it will work for some time yet so an investment soley in the hopes of an AD cure is a long term risk.

Add a Topic
1447
Add a Topic
2866
Add a Topic
1447
Adrienne
Guest
Adrienne
July 21, 2011 8:45 pm

There are various things that can remove plaque: multienzymes, chelation therapy for the metals in the brain, magnetic therapy, and amino acids. Everything that involves the brain, including M.S., involves deficiencies of amino acids. Doctors never talk about a.a.'s because they cannot patent them and make loads of money. Unless there are amino acids in the drug, I would not touch it. BTW, anyone who has a loved one with dementia should learn about carnosine, which are two amino acids which helps improve memory/recall. Just my 2cents worth.

Add a Topic
5513
tomt
tomt
July 22, 2011 1:09 am

Thanks for your 2 cents Adrienne.
Recently a "mailer" was pitching an extract from tobbaco plant (not nicotine) was tested and shoed a terrific response (w/amloids I think) that were fundamental in the plaque of AD. An anti inflamatory effect that would help us with many conditions. There was more to this story stock, including a lawsuit that could end it all if it went against them.
Theey will never run out of STORY stocks. The story is real enough, where they don't go to jail for it, but.. in these cases it "pays" to make a very small bet initially, where a reversal , even a severe one won't cause you to sell. Do this enough times and your bound to get lucky , or at least have better odds than the lottery. You will still have funds to ladder into your winners on pullbacks.
BTW, I thought "wouldn't be irony for tobacco to offer a health benefit . Not so far.

Add a Topic
5971
Add a Topic
501
Patty
Patty
July 22, 2011 5:12 am

Check out the medical doctor on YouTube whose husband had Alzheimer's disease. She has a bunch of short videos regarding Alzheimer's and coconut oil. After doing some research, she discovered coconut oil contains lauric acid, which is a component of mother's milk. After she started giving her husband about two tablespoons per day, he recovered some of his functioning and improved a noticeable amount. She said it didn't cure Alzheimer's, but it did stop some of the progression of Alzheimer's, and it made a difference. My mother-in-law had Alzheimer's, and I wish we had known about coconut oil back then. I figure if it's good for Alzheimer's, it ought to be good for normal brain functioning, so I eat 2 T. of organic coconut oil on crackers, sprinkled with cinnamon powder, per day. (I've read that Alzheimer's is considered to be a third form of diabetes by some, so figure if cinnamon powder helps people with insulin resistance, frankly, it can't hurt.) I doubt a pharmaceutical company would develop a drug using coconut oil since they can't patent it. Too simple, besides! This info won't help anyone seeking investing info, but it might help someone with Alzheimer's…and members of their families who care for them! Just my opinion, naturally!

Add a Topic
2866
Add a Topic
899
Add a Topic
359
mickey
Guest
mickey
July 22, 2011 11:11 am

I have been following ACAD for the last three years, I have stock positions. They have a drug delivery system that is in the phase two and phase three trials. The drug is called primavansarin. It also is trials for glaucoma, Parkinson's, rheumatoid arthritis, and Alzheimer. The drugs have a means off offsetting side affects. There has been a lot of cash infused into this company. As a rule, I look closely at following the money.

Add a Topic
5971
Add a Topic
3755
Yoonki Lee
Guest
October 16, 2011 3:00 am
Reply to  mickey

Dear:

We would like to exchange the informaton about the alzheimer with you.

Best regards,

Yoonki Lee

Mark
Guest
Mark
July 22, 2011 1:14 pm

On June 11th I lost my 92 yr old father to Alzheimers. A highly educated man whom was
a Pharmacist early in his career & thru out his life refused to take any pharmacueticals as he
say believed they were far more dangerous to one's health than natural herbs ,supplements & vitamins. When he first began showing sings of dementia we began a protocol shown below which halted the ALZ in it's tracks. The areas top nerologist tested him annually using the MMS evaluation . He scores remained very high until he was forced to stay at a skilled care facility where they refused his natural supplements ( another story) After two weeks he began to deteriorate by 30 he was very bad & I removed him from the facility & took him for an evalution. There was a enormous, abnormal drop in
his scores so much so the Doctor order MRI & other tests. I took him home & restarted the protocol below at higher than normal dosages . Within 1 week he began to come around ,within thirty days he was ready for a new MMS test. His scores were nearly back to normal , a documented 70% improvement from the previous test. Unfortunately he fell & had to go to the Hospital & then skilled care for another 60 days w/ no supplements . The alzheimers came back in force and affected his ability to swallow. Modern medicine let him starve to death a all to common practice in todays hospitals.

The protocol is : 2 to 4 tbl spoons of Virgin Coconut Oil
32 oz of pure Apple Juice spread thru out the day
1 250mg tab of Niacinnmide every three hours total 6 per day
1 840 mg 3 times per day no food
+ 64 ounces of distilled water min daily
Acetyl -l- Carnitine 1000 to 1500 mg daily
Alpha-glycerylphosphorycholine ( Alpha-GPC) 250 mg daily
Curcumin 1000 to 2000 mg daily
High Quality Fish Oil (kirkland) 4grms daily
Phosphatidylserine 100-200 mg daily
Vinpocetine 10 to 30 mg twice per day.
All these supplements can be found at near wholesale pricing & pharmcuetical grade
at http://www.vitacost.com

Patient ideally should also undergo "chelation therapy " & follow Chelation doctors dietary
directions for persons with dementia / Alzheimers.

As for Novo & their diabetes drug (s) I find it amazing that the world is so gullible & takes this poison. There are natural supplements that have been tested & shown to as good if not better than mainstream diabetes drugs w/o any of the deadly & additive side effects.

Hope this post helps someone out there ….

Add a Topic
3555
Add a Topic
5399
Add a Topic
5399
Clark
Guest
Clark
July 23, 2011 11:27 am

Mark- This very interesting–Could you please fill in the name of the supplement (840 MG, 3x day)? Thanks, max

Myron Martin
Guest
July 24, 2011 1:58 pm

Cudos to Mark (and others) for having the courage to expose the drug industry for what it is, a parasitical industry playing on peoples fear and ignorance. DRUGS CURE NOTHING, at best they relieve symptoms temporarily, but in the process INTERFERE with normal bodily processes and in the end cause more damage than they what they alleviate.

Every drug is a POISON to a greater or lesser extent and ALL have side effects, many that do not manifest themselves until years after their ingestion. It surprises me that the one thing that has NOT been mentioned by anybody is that it is a known fact that Alzheimers patients show a high concentration of aluminum in the brain. I would bet that if people universally gave up using aluminum cookware (unless coated so as not to come in contact with food) and stopped the use of deodorants with an aluminum base in a generation we would see a dramatic drop in cases of Alzheimers.

fixer
Guest
fixer
July 24, 2011 2:36 pm

Mark, and others who believe big Pharma has nothing to offer. Do you know that big Pharma and their private army (FDA) is trying to do away with all supplements through back-door codex altimarious (sp). Google healthfreedomusa.org for more…

Add a Topic
3022
Add a Topic
3555
Infinet
Member
July 31, 2011 1:28 pm

I knew a lady who,about a year after a fall during which she knocked her head badly,ddeveloped Alzheimer.
Her husband took her to see a top specialist in London.I had asked the husband to point out the head injury incident to the specialist.whose comment was "oh yes,a lot of
Alzheimer patients seem to have had a head injury"….without seemingly making any possible connection,

I see a possible connection. Head and neck injuries cause inflammation and
muscle tension /structural distortions,whch , if unresolved,can subtly affect the blood
supply to the brain,which would result in reduced oxygen and nutrient supply,which
in turn can lead to degenerative changes such as are seen in Alzheimer ,or indeed
many other dis-eases (lack of ease!)
This vital connection between Structure and Function is still largely ignored and
may well hold an important key.An engineer would probably understand it better
than many doctors.

Add a Topic
5554

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
34
0
Would love your thoughts, please comment.x
()
x